ANDREW BADACHHAPE to Hepatoblastoma
This is a "connection" page, showing publications ANDREW BADACHHAPE has written about Hepatoblastoma.
Connection Strength
0.842
-
Investigating the oncogenic role of aberrant EZH2 in hepatoblastoma. Sci Rep. 2026 Feb 06; 16(1).
Score: 0.194
-
Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
Score: 0.191
-
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 04; 80(4):610-621.
Score: 0.168
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.153
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
Score: 0.137